We evaluated the use of a novel High Density Mesh Ablator (HDMA) catheter in combination with three-dimensional navigation for the treatment of paroxysmal atrial fibrillation. The HDMA catheter was used to carry out pulmonary vein isolation in a consecutive series of patients. Three-dimensional geometry of the left atrial-pulmonary vein (LA-PV) junctions were first created with the HDMA catheter. Ostial, proximal and distal sites within the pulmonary veins were tagged with catheter shadows on the created geometry to allow for re-interrogation of these exact sites after ablation. The HDMA catheter was successfully used to create three dimensional geometry of the LA-PV junction in a total of 20 pulmonary veins which involved 5 patients. In all cases, ostial ablation alone was sufficient to achieve electrical isolation. No significant pulmonary vein stenosis was seen acutely after ablation. We describe the successful use of the novel HDMA catheter to create three-dimensional geometry of the LA-PV junction to assist with pulmonary vein isolation.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398827 | PMC |
http://dx.doi.org/10.4022/jafib.203 | DOI Listing |
Europace
August 2018
Department of Cardiology, ASZ Hospital Aalst, Merestraat 80, Aalst, Belgium.
Aims: To define predictors of complications of pulmonary vein isolation (PVI) and compare safety between different ablation techniques.
Methods And Results: One thousand patients with atrial fibrillation (AF) (age 60 ± 10, 72% males, CHA2DS2-VASc score 1 ± 1) underwent PVI using various techniques: conventional PVI (CPVI) using mapping with irrigated point-per-point RF ablation (n = 576), multi-electrode RF ablation with the pulmonary vein ablation catheter (PVAC) (n = 272) or high density mesh ablator (HDMA) (n = 59) and cryoballoon (CB) ablation (n = 93). A complication was defined as any procedure-related adverse event resulting in permanent injury or death, requiring intervention or treatment, or prolonging/requiring hospitalization for >48 h.
Int J Med Sci
July 2013
Department of Cardiology and Angiology, Klinikum Merheim, University Witten/Herdecke/Germany, Cologne, Germany.
Background: Pulmonary Vein Isolation (PVI) is evolving as an established treatment option in atrial fibrillation (AF). Different fluoroscopy-guided ablation devices exist either on the basis of expandable circumferential and mesh designs with mapping and ablation of pulmonary vein potentials, or of a balloon technology, a "single shot" device with a purely anatomical approach. Systematic comparisons between procedure duration (PD), fluoroscopy time (FT) and clinical outcome in using different ablation tools are lacking in the literature.
View Article and Find Full Text PDFKardiol Pol
November 2010
Klinika Kardiologii, Centrum Medyczne Kształcenia Podyplomowego, Szpital Grochowski, Warszawa.
We present a case of a 49 year-old man without structural heart disease who suffered from frequent episodes of atrial fibrillation. We performed pulmonary vein isolation using a new system High-Density Mesh Ablation. All four pulmonary veins were isolated and during an 8-month follow-up period no arrhythmia recurrences were noted.
View Article and Find Full Text PDFEuropace
October 2010
Department of Cardiology, Antwerp Cardiovascular Institute Middelheim, ZNA Middelheim, Lindendreef 1, 2020 Antwerpen, Belgium.
Aims: To analyse procedural results and clinical outcome of paroxysmal atrial fibrillation (AF) ablation using the 30 and 35 mm high-density mesh ablator (HDMA, Bard Electrophysiology).
Methods And Results: Sixty-four consecutive patients were ablated with the HDMA catheter (26 with the 30 mm, 38 with the 35 mm device). If pulmonary vein (PV) isolation was unsuccessful, ablation was continued using a conventional 4 mm ablation catheter.
J Interv Card Electrophysiol
October 2010
Department of Cardiology and Angiology, Ruhr-University Bochum, Hölkeskampring 40, 44625, Herne, Germany.
Purpose: The high density mesh ablator (HDMA), a mesh electrode catheter using radiofrequency delivery for pulmonary vein isolation (PVI) in patients with atrial fibrillation (AF), has been shown to have a high acute ablation success rate. The primary endpoint of our study was the efficacy of HDMA to maintain sinus rhythm (SR), and the secondary endpoint is its efficacy to reduce AF burden in an 18-month follow-up.
Methods: Forty-two patients with AF [25 patients with paroxysmal AF (PAF, 59.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!